Where Spike in cutaneous lesions is reported
Also listed as: Tissue spike expression
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| PACVS | ↑ elevated | Normal skin | Dermatological vaccine reactions | Sano et al. 2025 |
Frequently asked questions
In which conditions is Spike in cutaneous lesions altered?
In the OSMF atlas Spike in cutaneous lesions is reported in PACVS. It is elevated in 1 across 1 entries.
Is there a standard clinical test for Spike in cutaneous lesions?
The atlas entries for Spike in cutaneous lesions do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Spike in cutaneous lesions result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-30 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.